IPSEN (IPN.PA) Stock Fundamental Analysis
Europe - EPA:IPN - FR0010259150 - Common Stock
121.55 EUR
-0.45 (-0.37%)
IPN gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 52 industry peers in the Pharmaceuticals industry. IPN is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. IPN is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year IPN was profitable.
In the past year IPN had a positive cash flow from operations.
Each year in the past 5 years IPN has been profitable.
In the past 5 years IPN always reported a positive cash flow from operatings.
1.2 Ratios
IPN has a Return On Assets (6.56%) which is comparable to the rest of the industry.
IPN has a Return On Equity of 10.59%. This is comparable to the rest of the industry: IPN outperforms 50.00% of its industry peers.
IPN's Return On Invested Capital of 14.88% is fine compared to the rest of the industry. IPN outperforms 75.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for IPN is below the industry average of 15.23%.
The 3 year average ROIC (12.97%) for IPN is below the current ROIC(14.88%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.56% | ||
| ROE | 10.59% | ||
| ROIC | 14.88% |
ROA(3y)9.04%
ROA(5y)10.56%
ROE(3y)14.84%
ROE(5y)18.77%
ROIC(3y)12.97%
ROIC(5y)15.34%
1.3 Margins
IPN's Profit Margin of 11.91% is in line compared to the rest of the industry. IPN outperforms 53.85% of its industry peers.
IPN's Profit Margin has declined in the last couple of years.
IPN has a Operating Margin of 26.01%. This is in the better half of the industry: IPN outperforms 69.23% of its industry peers.
In the last couple of years the Operating Margin of IPN has declined.
IPN's Gross Margin of 83.32% is amongst the best of the industry. IPN outperforms 88.46% of its industry peers.
In the last couple of years the Gross Margin of IPN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 26.01% | ||
| PM (TTM) | 11.91% | ||
| GM | 83.32% |
OM growth 3Y-13.94%
OM growth 5Y-4.28%
PM growth 3Y-25.63%
PM growth 5YN/A
GM growth 3Y-0.54%
GM growth 5Y0.2%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), IPN is creating value.
Compared to 1 year ago, IPN has more shares outstanding
The number of shares outstanding for IPN remains at a similar level compared to 5 years ago.
IPN has a better debt/assets ratio than last year.
2.2 Solvency
IPN has an Altman-Z score of 4.48. This indicates that IPN is financially healthy and has little risk of bankruptcy at the moment.
IPN has a better Altman-Z score (4.48) than 65.38% of its industry peers.
IPN has a debt to FCF ratio of 1.69. This is a very positive value and a sign of high solvency as it would only need 1.69 years to pay back of all of its debts.
The Debt to FCF ratio of IPN (1.69) is better than 88.46% of its industry peers.
A Debt/Equity ratio of 0.20 indicates that IPN is not too dependend on debt financing.
IPN has a better Debt to Equity ratio (0.20) than 76.92% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 1.69 | ||
| Altman-Z | 4.48 |
ROIC/WACC1.89
WACC7.87%
2.3 Liquidity
IPN has a Current Ratio of 1.98. This is a normal value and indicates that IPN is financially healthy and should not expect problems in meeting its short term obligations.
IPN has a Current ratio of 1.98. This is in the better half of the industry: IPN outperforms 76.92% of its industry peers.
IPN has a Quick Ratio of 1.80. This is a normal value and indicates that IPN is financially healthy and should not expect problems in meeting its short term obligations.
IPN has a Quick ratio of 1.80. This is amongst the best in the industry. IPN outperforms 82.69% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.8 |
3. Growth
3.1 Past
IPN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.24%, which is quite good.
IPN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.79% yearly.
IPN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.45%.
Measured over the past years, IPN shows a small growth in Revenue. The Revenue has been growing by 5.83% on average per year.
EPS 1Y (TTM)12.24%
EPS 3Y4.15%
EPS 5Y8.79%
EPS Q2Q%44.4%
Revenue 1Y (TTM)9.45%
Revenue growth 3Y9.15%
Revenue growth 5Y5.83%
Sales Q2Q%9.67%
3.2 Future
The Earnings Per Share is expected to grow by 6.15% on average over the next years.
The Revenue is expected to grow by 5.61% on average over the next years.
EPS Next Y5.2%
EPS Next 2Y4.52%
EPS Next 3Y5.82%
EPS Next 5Y6.15%
Revenue Next Year7.07%
Revenue Next 2Y5.88%
Revenue Next 3Y6.24%
Revenue Next 5Y5.61%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
IPN is valuated reasonably with a Price/Earnings ratio of 11.84.
82.69% of the companies in the same industry are more expensive than IPN, based on the Price/Earnings ratio.
IPN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.76.
The Price/Forward Earnings ratio is 10.83, which indicates a very decent valuation of IPN.
76.92% of the companies in the same industry are more expensive than IPN, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.63. IPN is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.84 | ||
| Fwd PE | 10.83 |
4.2 Price Multiples
IPN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. IPN is cheaper than 94.23% of the companies in the same industry.
IPN's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. IPN is cheaper than 63.46% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.75 | ||
| EV/EBITDA | 5.76 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
IPN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.28
PEG (5Y)1.35
EPS Next 2Y4.52%
EPS Next 3Y5.82%
5. Dividend
5.1 Amount
IPN has a Yearly Dividend Yield of 1.16%.
Compared to an average industry Dividend Yield of 2.98, IPN has a dividend in line with its industry peers.
With a Dividend Yield of 1.16, IPN pays less dividend than the S&P500 average, which is at 2.31.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.16% |
5.2 History
The dividend of IPN has a limited annual growth rate of 3.72%.
Dividend Growth(5Y)3.72%
Div Incr Years1
Div Non Decr Years4
5.3 Sustainability
25.90% of the earnings are spent on dividend by IPN. This is a low number and sustainable payout ratio.
The dividend of IPN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP25.9%
EPS Next 2Y4.52%
EPS Next 3Y5.82%
EPA:IPN (10/30/2025, 2:07:58 PM)
121.55
-0.45 (-0.37%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners15.12%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner ChangeN/A
Market Cap10.19B
Revenue(TTM)3.76B
Net Income(TTM)447.90M
Analysts70
Price Target130.09 (7.03%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.16% |
Yearly Dividend1.2
Dividend Growth(5Y)3.72%
DP25.9%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.22%
PT rev (3m)0.62%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)3.35%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.21%
Revenue NY rev (3m)0.32%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.84 | ||
| Fwd PE | 10.83 | ||
| P/S | 2.71 | ||
| P/FCF | 19.75 | ||
| P/OCF | 11.35 | ||
| P/B | 2.41 | ||
| P/tB | 7.63 | ||
| EV/EBITDA | 5.76 |
EPS(TTM)10.27
EY8.45%
EPS(NY)11.22
Fwd EY9.23%
FCF(TTM)6.15
FCFY5.06%
OCF(TTM)10.71
OCFY8.81%
SpS44.86
BVpS50.46
TBVpS15.93
PEG (NY)2.28
PEG (5Y)1.35
Graham Number107.98
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.56% | ||
| ROE | 10.59% | ||
| ROCE | 18.07% | ||
| ROIC | 14.88% | ||
| ROICexc | 20.46% | ||
| ROICexgc | 77.25% | ||
| OM | 26.01% | ||
| PM (TTM) | 11.91% | ||
| GM | 83.32% | ||
| FCFM | 13.72% |
ROA(3y)9.04%
ROA(5y)10.56%
ROE(3y)14.84%
ROE(5y)18.77%
ROIC(3y)12.97%
ROIC(5y)15.34%
ROICexc(3y)20.33%
ROICexc(5y)25.52%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)15.75%
ROCE(5y)18.64%
ROICexgc growth 3Y-59.92%
ROICexgc growth 5Y-22.83%
ROICexc growth 3Y-29.05%
ROICexc growth 5Y-11.89%
OM growth 3Y-13.94%
OM growth 5Y-4.28%
PM growth 3Y-25.63%
PM growth 5YN/A
GM growth 3Y-0.54%
GM growth 5Y0.2%
F-Score7
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 1.69 | ||
| Debt/EBITDA | 0.5 | ||
| Cap/Depr | 55.54% | ||
| Cap/Sales | 10.15% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 53.9% | ||
| Profit Quality | 115.14% | ||
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.8 | ||
| Altman-Z | 4.48 |
F-Score7
WACC7.87%
ROIC/WACC1.89
Cap/Depr(3y)131.36%
Cap/Depr(5y)124.73%
Cap/Sales(3y)11.81%
Cap/Sales(5y)11.18%
Profit Quality(3y)85.87%
Profit Quality(5y)89.99%
High Growth Momentum
Growth
EPS 1Y (TTM)12.24%
EPS 3Y4.15%
EPS 5Y8.79%
EPS Q2Q%44.4%
EPS Next Y5.2%
EPS Next 2Y4.52%
EPS Next 3Y5.82%
EPS Next 5Y6.15%
Revenue 1Y (TTM)9.45%
Revenue growth 3Y9.15%
Revenue growth 5Y5.83%
Sales Q2Q%9.67%
Revenue Next Year7.07%
Revenue Next 2Y5.88%
Revenue Next 3Y6.24%
Revenue Next 5Y5.61%
EBIT growth 1Y66.72%
EBIT growth 3Y-6.06%
EBIT growth 5Y1.3%
EBIT Next Year32.82%
EBIT Next 3Y13.53%
EBIT Next 5Y8.05%
FCF growth 1Y-33.64%
FCF growth 3Y-35.67%
FCF growth 5Y-17.46%
OCF growth 1Y-8.92%
OCF growth 3Y-0.07%
OCF growth 5Y7.84%
IPSEN / IPN.PA FAQ
What is the fundamental rating for IPN stock?
ChartMill assigns a fundamental rating of 6 / 10 to IPN.PA.
Can you provide the valuation status for IPSEN?
ChartMill assigns a valuation rating of 6 / 10 to IPSEN (IPN.PA). This can be considered as Fairly Valued.
Can you provide the profitability details for IPSEN?
IPSEN (IPN.PA) has a profitability rating of 6 / 10.
What is the earnings growth outlook for IPSEN?
The Earnings per Share (EPS) of IPSEN (IPN.PA) is expected to grow by 5.2% in the next year.
Can you provide the dividend sustainability for IPN stock?
The dividend rating of IPSEN (IPN.PA) is 4 / 10 and the dividend payout ratio is 25.9%.